B. Riley Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)

Retrieved on: 2018-03-02 11:00:00

Tags for this article:

Click the tags to see associated articles and topics

B. Riley Begins Coverage on Akari Therapeutics (NASDAQ:AKTX). View article details on hiswai:

Excerpt

<div><b>Millennium Management</b> LLC grew its stake in Akari Therapeutics by 125.0% during the 4th quarter. <b>Millennium Management</b> LLC now owns 260,020 shares of the biopharmaceutical company's stock valued at $1,126,000 after purchasing an additional 144,477 shares in the last quarter. Finally, Hikari ...</div>

Article found on:

View Original Article